Skip to main content

Advertisement

Table 2 Baseline Characteristics

From: An australian audit of vaccination status in children and adolescents with inflammatory bowel disease

Characteristic Audit (%) IBD Database (%) P value
Sex (Female) 50 41 0.12
Diagnosis    
   Crohn's disease 74 70 0.4
   Ulcerative colitis 23 19 0.4
   Indeterminate colitis 3 11 0.01
Length time since diagnosis (range: years)    
   ≤ 5years 64 55 0.12
   ≥6 years 36 45 0.12
Medication exposure (ever)*    
   Oral steroids (> 3 months duration) 77   
   Antiinflammatory (sulphasalazine/osalazine/mesalazine) 88   
   Immunosuppressive (azothioprine or methotrexate) 59   
   Biologic therapy (Anti TNF Infliximab) 20   
  1. * some patients had multiple medications so percentages may exceed 100%